David S Allan

26PUBLICATIONS
36CO-AUTHORS
Artificial life and complex adaptive systemsHaematologyOther biomedical and clinical sciences not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 19, 2026
How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?

|Sep 26, 2025
Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not Proceeding.

Madeline Monaghan, An Duong, Kalina Abrol

|Apr 01, 2025
Use of non-qualifying umbilical cord blood units to support research and quality assurance by the Canadian Blood Services Cord Blood Bank.

David S Allan, Matthew D Seftel, An Duong

|Jan 24, 2025
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.

Matthew D Seftel, Grace Musto, David Allan

|May 24, 2024
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.

Gaganvir Parmar, Matthew D Seftel, Kathy Ganz

|Mar 27, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.

Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic

Pageof 5

Frequent Collaborators

3 joint publications

John T Blake

3 joint publications

Manoj M Lalu

2 joint publications

Alvin Tieu

2 joint publications

Matthew D Seftel